SCHEMBL1695382

SCHEMBL1695382

Cn1nc(COS(C)(=O)=O)c2ccccc21

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1A2 P05177 1/20 0.43
▸ CYP3A4 P08684 1/20 0.43
▸ CYP2D6 P10635 1/20 0.43
▸ KDM4E B2RXH2 1/20 0.40
▸ CNR1 P21554 1/20 0.40
▸ CNR2 P34972 1/20 0.40
▸ CCR4 P51679 1/20 0.38
▸ SLC16A3 O15427 1/20 0.37
▸ FEN1 P39748 1/20 0.37
▸ HTR2A P28223 1/20 0.36
▸ HTR2C P28335 1/20 0.36
▸ HTR2B P41595 1/20 0.36
▸ ELANE P08246 1/20 0.36
▸ DDB1 Q16531 3/20 0.35
▸ CRBN Q96SW2 3/20 0.35
▸ SMN1; SMN2 Q16637 1/20 0.35
▸ ENPP1 P22413 1/20 0.34
▸ XIAP P98170 1/20 0.34
▸ MAPK13 O15264 1/20 0.34
▸ EIF2AK2 P19525 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23174835 0.85 KDM4E (0.42) CYP1A2CYP3A4CYP2D6KDM4ECNR1
SCHEMBL3437213 0.80 ELANE (0.46) CYP1A2CYP3A4CYP2D6KDM4ESLC16A3
SCHEMBL14892448 0.77 KDM4E (0.41) KDM4ECNR1CNR2SLC16A3FEN1
SCHEMBL13330186 0.75 ELANE (0.42) CYP1A2CYP3A4CYP2D6KDM4ESLC16A3
SCHEMBL20548896 0.75 KDM4E (0.44) CYP1A2KDM4ECNR1CNR2CCR4
SCHEMBL8414862 0.75 CNR1 (0.48) KDM4ECNR1CNR2SMN1; SMN2
SCHEMBL1273316 0.75 CCR4 (0.39) KDM4ECNR1CNR2CCR4FEN1
SCHEMBL17910321 0.73 KDM4E (0.41) CYP1A2KDM4ECNR1CNR2FEN1
SCHEMBL5009531 0.73 L3MBTL1 (0.45) CYP1A2KDM4ECNR1CNR2FEN1
SCHEMBL29585194 0.73 KDM4E (0.41) CYP1A2KDM4ECNR1CNR2FEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011138657-A1 ARYL SUBSTITUTED OLEFINIC COMPOUNDS AS PDE10A INHIBITORS GLENMARK PHARMACEUTICALS S.A. (CH) 2011-11-10 — — WO disclosed
WO-2011012622-A1 BENZOXAZINONE DERIVATIVES FOR THE TREATMENT OF GLYTL MEDIATED DISORDERS GLAXO GROUP LIMITED (GB) 2011-02-03 — — WO disclosed
Send feedback